|
Variables
|
MMR status
|
p value
|
|---|
|
p-MMR
|
d-MMR
|
|---|
|
Sex
| | |
0.102
|
|
male
|
516/2031 (25.4%)
|
55/2031 (2.7%)
| |
|
female
|
1375/2031 (67.7%)
|
85/2031 (4.2%)
| |
|
Lauren type
| | |
0.012*
|
|
Diffuse/mixed
|
1201/2031 (59.1%)
|
74/2031 (3.6%)
| |
|
intestinal
|
690/2031 (34%)
|
66/2031 (3.2%)
| |
|
Differentiation
| | |
0.256
|
|
poorly
|
1264/2031 (62.2%)
|
87/2031 (4.3%)
| |
|
well-moderately
|
627/2031 (30.9%)
|
53/2031 (2.6%)
| |
|
T stage
| | |
0.038
|
|
pT3 + T4
|
1193/2031 (58.7%)
|
88/2031 (4.3%)
| |
|
pT1 + T2
|
698/2031 (34.4%)
|
52/2031 (2.6%)
| |
|
Lymphnode metastasis
| | |
0.246
|
|
LNM+
|
1121/2031 (55.2%)
|
76/2031 (3.7%)
| |
|
LNM-
|
770/2031 (37.9%)
|
64/2031 (3.2%)
| |
|
PD-L1 expression
| | |
0.000*
|
|
PD-L1 -
|
1337/2031 (65.8%)
|
69/2031 (3.4%)
| |
|
PD-L1 > =1%
|
554/2031 (27.3%)
|
71/2031 (3.5%)
| |
